How Does PowerFULL Work?
PureDOPA, containing an extract of Mucuna Pruriens induces an increase in endogenous (natural) LevaDopa production that vastly outperforms synthetic LevaDopa with 110% higher peak concentrations, 165% longer peak concentrations, and an onset time around 50% shorter [1]. LD itself then leads to an increase in natural Growth Hormone production which research has shown to be staggering, even in healthy, normal subjects [3, 4]. Research has also shown that this increase is most likely occurring by way of LD-induced hypothalamtic GHRH (growth hormone releasing hormone) production [2, 4].
If the GH Increase Came From Synthetic L-DOPA, How Does PowerFULL Compare?
It is true the increases of plasma GHRH and GH [1,2,3,4 ] have been noted as a result of synthetic L-DOPA administration. However, Mucuna P., has demonstrated an efficacy at raising L-DOPA (with its subsequent effect on GHRH and GH) of twice to three times that of synthetic L-DOPA [1, 6, 7]. This increase in effectiveness stems from Mucuna most likely possessing either independent L-DOPA enhancing adjuvents, or possibly containing inherent decarboxylase inhibitors [6. 7. 8]. The latter scenario is likely as Dopamine and its metabolites have not been found in the nigrostriatal tract after Mucuna administration [8], as well as a lack of dyskensia in Parkinson’s patients [1] and lack of side-effects in normal patients [3]. This data is indicative of a lack of Dopaminergic transmission in peripheral tissues.
I Have Read L-DOPA Has Some Unwanted Side-Effects, What About PowerFULL?
Synthetic L-DOPA has been noted to have many adverse side-effects including hypertension, dyskenisia (uncontrollable movement), dizziness, nausea, and so on. However, Mucuna has not shown these same side-effects in Parkinson’s patients [1], and L-DOPA administration has not displayed these same side-effects in healthy, normal subjects [2, 3].
What About Natural Dopamine Production, Doesn’t L-DOPA Decrease That?
Along with the above side-effects, synthetic L-DOPA has been shown to have damaging effects to dopamine ions in the region of the brain most responsible for dopamine transmission (the substantia nigra). This can lead to an aggregate decrease in endogenous dopamine production. However, Mucuna has been shown to have neuro-restorative effects, actually increasing levels of serotonin, dopamine, levadopa, and norepinephrine [9]. This is most likely due to a more efficient transmission of dopamine, and Mucuna containing NADH and COQ-10, both powerfull neurorestorative compounds [9. 10].
So You’re Saying Even as a Health Adult, PowerFULL Will Effect Me?
Yes. As shown Mucuna is vastly more effective than synthetic L-DOPA at raising L-DOPA and Dopamine levels [1, 6, 7], and also has been administered to health adults with success [5]. Coupled with the research in healthy, normal adults as it pertains to synthetic L-DOPA administration [2. 3. 4], and PowerFULL being standardized to 50% L-DOPA, the research is overwhelmingly positive.
REFERENCES:
[1] Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study. Katzenschlager R, et al.
[2] L-dopa stimulates release of hypothalamic growth hormone-releasing hormone in humans. K Chihara, et al.
[3]Intravenous levodopa administration in humans based on a two-compartment kinetic model. Mollie Gordon, et al.
[4] Effect of oral administration of L-dopa on the plasma levels of growth hormone-releasing hormone (GHRH) in normal subjects and patients with various endocrine and metabolic diseases. Mitsuhashi S, et al.
[5] Bioavailability of L-DOPA from HP-200 - a Formulation of Seed Powder of Mucuna pruriens (Bak): a Pharmacokinetic and Pharmacodynamic Study. S.Mahajani et al.,
[6] Mucuna pruriens proves more effective than L-DOPA in Parkinson's disease animal model. Ghazala Hussian, Bala V. Manyam
[7] Beans (Mucuna Pruriens) For Parkinsons Disease:An Herbal Alternative. Bala V. Manyam, M.D.,
[8] Effect of antiparkinson drug HP-200 (Mucuna pruriens) on the central monoaminergic neurotransmitters. Bala V. Manyam et al.,
[9] Neuroprotective effects of the antiparkinson drug Mucuna pruriens. Manywam et al.,
[10] Protecting Axonal Degeneration by Increasing Nicotinamide Adenine Dinucleotide Levels in Experimental Autoimmune Encephalomyelitis Models. Shinjiro Kaneko, et al.